SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,782,842 | +8.1% | 64,666 | +17.8% | 0.01% | +25.0% |
| Q2 2023 | $1,649,993 | -44.5% | 54,890 | -33.2% | 0.00% | -42.9% |
| Q1 2023 | $2,975,244 | +144.5% | 82,121 | +140.7% | 0.01% | +133.3% |
| Q4 2022 | $1,216,918 | +1.4% | 34,116 | -3.7% | 0.00% | -25.0% |
| Q3 2022 | $1,200,000 | +29900.0% | 35,443 | +28483.1% | 0.00% | – |
| Q2 2022 | $4,000 | -99.9% | 124 | -99.9% | 0.00% | -100.0% |
| Q1 2022 | $4,083,000 | +5.9% | 126,330 | -4.4% | 0.01% | +28.6% |
| Q4 2021 | $3,855,000 | -24.9% | 132,193 | -32.5% | 0.01% | -30.0% |
| Q1 2021 | $5,130,000 | +12.4% | 195,947 | +8.0% | 0.01% | +11.1% |
| Q4 2020 | $4,566,000 | +20.8% | 181,467 | +0.0% | 0.01% | 0.0% |
| Q3 2020 | $3,781,000 | +230.5% | 181,416 | +276.7% | 0.01% | +200.0% |
| Q2 2020 | $1,144,000 | -75.3% | 48,161 | -75.3% | 0.00% | -70.0% |
| Q4 2019 | $4,626,000 | -40.2% | 195,025 | -30.8% | 0.01% | -47.4% |
| Q3 2019 | $7,740,000 | +56.2% | 281,667 | +88.1% | 0.02% | +58.3% |
| Q2 2019 | $4,955,000 | +375.1% | 149,732 | +403.2% | 0.01% | +300.0% |
| Q1 2019 | $1,043,000 | -89.7% | 29,758 | -82.4% | 0.00% | -90.0% |
| Q2 2018 | $10,099,000 | +615.2% | 168,735 | +447.4% | 0.03% | +650.0% |
| Q1 2018 | $1,412,000 | +2214.8% | 30,826 | +1918.7% | 0.00% | – |
| Q4 2017 | $61,000 | -94.8% | 1,527 | -94.8% | 0.00% | -100.0% |
| Q3 2017 | $1,170,000 | +1525.0% | 29,238 | +1652.9% | 0.00% | – |
| Q2 2017 | $72,000 | +24.1% | 1,668 | -10.5% | 0.00% | – |
| Q1 2017 | $58,000 | +7.4% | 1,863 | -12.9% | 0.00% | – |
| Q4 2016 | $54,000 | -15.6% | 2,140 | -17.6% | 0.00% | – |
| Q3 2016 | $64,000 | +8.5% | 2,598 | -10.7% | 0.00% | – |
| Q2 2016 | $59,000 | -15.7% | 2,909 | -36.8% | 0.00% | – |
| Q1 2016 | $70,000 | +42.9% | 4,602 | +25.3% | 0.00% | – |
| Q4 2015 | $49,000 | – | 3,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |